The Centers for Medicare and Medicaid Services announced Friday that 64 Part B drugs will have a reduced price for Medicare ...
GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance ...
During the worst part of the shortage in June and July 2023, physicians swapped the usual drug for a substitute—sometimes one ...